<VariationArchive VariationID="3235152" VariationName="NM_017415.3(KLHL3):c.1554_1570dup (p.Asn524delinsSerLysTrpGlnThrTer)" VariationType="Duplication" Accession="VCV003235152" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2024-06-10" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3394271" VariationID="3235152">
      <GeneList>
        <Gene Symbol="KLHL3" FullName="kelch like family member 3" GeneID="26249" HGNC_ID="HGNC:6354" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="137617500" stop="137736089" display_start="137617500" display_stop="137736089" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="136953188" stop="137071778" display_start="136953188" display_stop="137071778" Strand="-" />
          </Location>
          <OMIM>605775</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_017415.3(KLHL3):c.1554_1570dup (p.Asn524delinsSerLysTrpGlnThrTer)</Name>
      <CanonicalSPDI>NC_000005.10:137628317:TCATGTCTGCCACTTGCT:TCATGTCTGCCACTTGCTCATGTCTGCCACTTGCT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="137628317" stop="137628318" display_start="137628317" display_stop="137628318" variantLength="17" positionVCF="137628317" referenceAlleleVCF="T" alternateAlleleVCF="TTCATGTCTGCCACTTGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="136964006" stop="136964007" display_start="136964006" display_stop="136964007" variantLength="17" positionVCF="136964006" referenceAlleleVCF="T" alternateAlleleVCF="TTCATGTCTGCCACTTGC" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.137628319_137628335dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.137628319_137628335dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.136964008_136964024dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.136964008_136964024dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032569.1" sequenceAccession="NG_032569" sequenceVersion="1" change="g.112757_112773dup">
            <Expression>NG_032569.1:g.112757_112773dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001257194.1" sequenceAccession="NM_001257194" sequenceVersion="1" change="c.1458_1474dup">
            <Expression>NM_001257194.1:c.1458_1474dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001244123.1" sequenceAccession="NP_001244123" sequenceVersion="1" change="p.Asn492delinsSerLysTrpGlnThrTer">
            <Expression>NP_001244123.1:p.Asn492delinsSerLysTrpGlnThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001257195.2" sequenceAccession="NM_001257195" sequenceVersion="2" change="c.1308_1324dup">
            <Expression>NM_001257195.2:c.1308_1324dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001244124.1" sequenceAccession="NP_001244124" sequenceVersion="1" change="p.Asn442delinsSerLysTrpGlnThrTer">
            <Expression>NP_001244124.1:p.Asn442delinsSerLysTrpGlnThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017415.3" sequenceAccession="NM_017415" sequenceVersion="3" change="c.1554_1570dup" MANESelect="true">
            <Expression>NM_017415.3:c.1554_1570dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_059111.2" sequenceAccession="NP_059111" sequenceVersion="2" change="p.Asn524delinsSerLysTrpGlnThrTer">
            <Expression>NP_059111.2:p.Asn524delinsSerLysTrpGlnThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017415.3(KLHL3):c.1554_1570dup (p.Asn524delinsSerLysTrpGlnThrTer) AND Pseudohypoaldosteronism type 2D" Accession="RCV004566388" Version="1">
        <ClassifiedConditionList TraitSetID="7907">
          <ClassifiedCondition DB="MedGen" ID="C3469605">Pseudohypoaldosteronism type 2D</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-07-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-10" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7907" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16836" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FAMILIAL HYPERKALEMIC HYPERTENSION</ElementValue>
                <XRef Type="MIM" ID="614495" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL DOMINANT OR RECESSIVE</ElementValue>
                <XRef Type="Allelic variant" ID="605775.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pseudohypoaldosteronism type 2D</ElementValue>
                <XRef ID="PSEUDOHYPOALDOSTERONISM%2C+TYPE+IID/9187" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013781" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PHA2D</ElementValue>
                <XRef Type="MIM" ID="614495" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FHHT</ElementValue>
                <XRef Type="MIM" ID="614495" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17372" />
                <XRef ID="17372" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pseudohypoaldosteronism type II (PHAII) is characterized by hyperkalemia despite normal glomerular filtration rate (GFR) and frequently by hypertension. Other associated findings in both children and adults include hyperchloremia, metabolic acidosis, and suppressed plasma renin levels. Aldosterone levels are variable, but are relatively low given the degree of hyperkalemia (elevated serum potassium is a potent stimulus for aldosterone secretion). Hypercalciuria is well described.</Attribute>
                <XRef ID="NBK65707" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22073419</ID>
                <ID Source="BookShelf">NBK65707</ID>
              </Citation>
              <XRef ID="300525" DB="Orphanet" />
              <XRef ID="757" DB="Orphanet" />
              <XRef ID="C3469605" DB="MedGen" />
              <XRef ID="MONDO:0013781" DB="MONDO" />
              <XRef Type="MIM" ID="614495" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9763103" SubmissionDate="2024-05-11" DateLastUpdated="2024-06-09" DateCreated="2024-06-09">
        <ClinVarSubmissionID localKey="chr5:136964006_136964007insTCATGTCTGCCACTTGC_614495" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005043167" DateUpdated="2024-06-09" DateCreated="2024-06-09" Type="SCV" Version="1" SubmitterName="MVZ Medizinische Genetik Mainz" OrgID="509214" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG Criteria: PVS1, PM2_SUP, PP4 (ACMG Version 3)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">UK Practice Guidelines For Variant Classification V4 01 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sman24qb/uk-practice-guidelines-for-variant-classification-v4-01-2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Paired-end mapping</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0002153" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0004319" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0032066" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KLHL3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="5" alternateAllele="TTCATGTCTGCCACTTGC" referenceAllele="T" start="136964006" stop="136964006" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">chr5:136964006_136964007insTCATGTCTGCCACTTGC</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614495" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14440237</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9763103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0032066" MappingRef="HP">
        <MedGen CUI="C4732833" Name="Decreased serum bicarbonate concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9763103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0002153" MappingRef="HP">
        <MedGen CUI="C0020461" Name="Hyperkalemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9763103" TraitType="Disease" MappingType="XRef" MappingValue="614495" MappingRef="OMIM">
        <MedGen CUI="C3469605" Name="Pseudohypoaldosteronism type 2D" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9763103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0004319" MappingRef="HP">
        <MedGen CUI="C0857899" Name="Decreased circulating aldosterone level" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

